1. Mogensen CE. Practice guidelines for chronic kidney disease. Ann Int Med2004; 140: 933-4. doi.10.7326/0003-4819-140-11-200406010-00025.

2. Girndt M. Diagnosis and treatment of chronic kidney disease. Internist2017; 58: 243-256. doi.10.1007/s00108-017-0195-2.

3. Rhee CM, You AS, Nguyen DV, Brunelli SM, Budoff MJ, Streja E, et al. Thyroid status and mortality in a prospective hemodialysis cohort. J Clin Endocrinol Metab 2017; 102: 1568-77. doi.10.1210/jc.2016-3616.

4. Kaptein EM, Quionverde H, Chooljian CJ, Tang WW, Friedman PE, Rodriquez HJ, et al. The thyroid in end stage renal disease. Medicine1988; 67: 187-97. doi.10.1097/00005792-198805000-0005.

5. LaFave L, Haselby D, Hart A. Endocrine Complications of Chronic Kidney Disease. Chronic Renal Disease. 2nd ed. Elsevier; 2020; 541-9. Doi.org/10.1016/B978-0-12-815876-0.00034-6.

6. Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol. 2000; 62: 439-66. doi: 10.1146/annurev.physiol.62.1.439.

7. Mohamedali M, Maddika SR, Vyas A, Iyer V, Cheriyath P. Thyroid Disorders and Chronic Kidney Disease. Int J Nephrol. 2014; 2014:1-6. doi.10.1155/2014/520281

8. Rhee CM. Thyroid disease in end stage renal disease. Curr Opin Nephrol Hyp2019; 28: 621-30. doi.10.1097/MNH.0000000000000542.

9. Cotoi L, Borcan F, Sporea I, Amzar D, Schiller O, Schiller A, et al. Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis. Diagnostics 2020; 10: 245. doi.10.3390/diagnostics10040245.

10. Iglesias P, Bajo MA, Selgas R, Díez JJ. Thyroid dysfunction and kidney disease an update. Rev Endocr Metab Dis2017; 18:131-44. doi.10.1007/s11154-016-9395-7.

11. Kutlay S, Atli T, Koseogullari O, Nergizoglu G, Duman N, Gullu S. Thyroid disorders in hemodialysis patients in an iodine deficient community. Art Org2005; 29: 329-32. doi.10.1111/j.1525-1594.2005.29055.x.

12. Vadakedath S, Kandi V. Dialysis a review of the mechanisms underlying complications in the management of chronic renal failure. Cureus2017; 9.1-8. doi.10.7759/cureus.1603.

13. Nederstigt C, Corssmit EP, de Koning EJ, Dekkers OM. Incidence and prevalence of thyroid dysfunction in type 1 diabetes. J Diabete Compl2016; 30: 420-5. doi.10.1016/j.jdiacomp. 2015.12.027.

14. Ray S, Ghosh S. Thyroid disorders and diabetes mellitus Double trouble. J Dia Res Ther 2016; 2: 1-7. doi.10.16966/2380-5544.113.

15. Nair A, Jayakumari C, Jabbar P, Jayakumar R, Raizada N, Gopi A, et al. Prevalence and associations of hypothyroidism in Indian patients with type 2 diabetes mellitus. J Thyr Res 2018; 2018. 1-7. doi.10.1155/2018/5386129.

16. ahmad Mirboluk A, Rohani F, Asadi R, Eslamian MR. Thyroid function test in diabetic ketoacidosis. Diabetes Metab Syndr. 2017; 11: S623-S5. Doi: 10.1016/j.dsx.2017.04.015.

17. Rosner MH, Reis T, Husainsyed F, Vanholder R, Hutchison C, Stenvinkel P, et al. Classification of uremic toxins and their role in kidney failure.Clin J Am Soc Nephrol2021; 16: 1918-28. doi.10.2215/CJN.02660221.

18. Nishikawa M, Ogawa Y, Yoshikawa N, Yoshimura M, Toyoda N, Shouzu A, et al. Plasma free thyroxine concentrations during hemodialysis in patients with chronic renal failure effects of plasma non-esterified fatty acids on FT4 measurement. Endocr J1996; 43: 487-93. doi.10.1507/endocrj.43.487.

19. Shamsadini S. [Effect of hemodialysis on thyroid hormone serum level of patients with chronic renal failure]. IJEM2000; 2: 187-90. (Persian).

20. Kutlay S, Atli T, Koseogullari O, Nergizoglu G, Duman N, Gullu S. Thyroid disorders in hemodialysis patients in an iodine deficient community. Art Org 2005; 29: 329-32. doi.10.1111/j.1525-1594.2005.29055.x.

21. Hakim RM, Lazarus MJ. Biochemical parameters in chronic renal failure. Am J Kid Dis1988; 11: 238-47. doi.10.1016/s0272-6386 (88) 80156-2.

22. Ozen KP, Asci G, Gungor O, Carrero JJ, Kircelli F, Tatar E, et al. Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol2011; 33: 305-12. doi.10.1159/000324883.

23. Utas C, Taskapan H, Oymak O, Akpolat T, Arinsoy T, Kelestimur F. Improvement of thyroid hormone profile and thyrotrophin surge alterations in hemodialysis patients on erythropoietin treatment. Clin Nephrol 2001; 55: 471-6.

24. Laurberg P. Mechanisms governing the relative proportions of thyroxine and triiodothyronine in thyroid secretion. Metabolism 1984; 33: 379-92. doi.10.1016/0026-0495 (84) 90203-8.

25. Burch HB. Drug effects on the thyroid. New Eng J Med2019; 381: 749-61. doi.10.1056/NEJMra

26. Kundra P, Burman KD. The effect of medications on thyroid function tests. Med Clin North Am 2012; 96: 283-95. doi.10.1016/j.mcna.2012.02.001.

27. Mortoglou A, Candiloros H. The serum triiodothyronine to thyroxine ratio in various thyroid disorders and after Levothyroxine replacement therapy. Hormones 2004; 3: 120-6. doi.10.14310/horm.2002.11120.

28. Maia AL, Goemann IM, Meyer EL, Wajner SM. Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. Endocrinology2011; 209: 283-97. doi.10.1530/JOE-10-0481.

29. Maia AL, Goemann IM, Souza Meyer E, Wajner SM. Type 1 iodothyronine deiodinase in human physiology and disease. Endocrinology 2011; 209, 283-297. doi.10.1530/JOE-10-0481.

30. Kawai M, Shoji Y, Onuma S, Etani Y, Ida S. Thyroid hormone status in patients with severe selenium deficiency. Clin Pediatr Endocrinol 2018; 27: 67-74. doi.10.1297/cpe.27.67.

31. Kralik A, Eder K, Kirchgessner M. Influence of zinc and selenium deficiency on parameters relating to thyroid hormone metabolism. Horm Metab Res1996; 28: 223-6. doi.10.1055/s-2007-979169.

32. Sobczak AIS, Stefanowicz F, Pitt SJ, Ajjan RA, Stewart AJ. Total plasma magnesium, zinc, copper and selenium concentrations in typeI and typeII diabetes. Biometals2019; 32: 123-38. doi.10.1007/s10534-018-00167-z.